TAG:
laboratory company
When Managers Make Decisions
By R. Lewis Dark | From the Volume V No. 15 – November 9, 1998 Issue
IF YOU OPERATE A CLINICAL LABORATORY, does the news of NeoPath, Inc.’s national contracts with Kaiser Permanente and SmithKline Beecham Clinical Laboratories (SBCL) alter your competitive position in the market? After all, it’s only been a few m…
Lab Specialists Acquired By Kroll-O’Gara Company
By Robert Michel | From the Volume V No. 15 – November 9, 1998 Issue
CEO SUMMARY: Laboratory Specialists of America has demonstrated a multi-year capability to increase revenues and boost earnings. The merger with Kroll-O’Gara provides it with ample capital to intensify its own acquisition program. One key to Laboratory Specialists’ success is its reco…
SmithKline’s Strategies Now Delivering Benefits
By Robert Michel | From the Volume V No. 14 – October 19, 1998 Issue
CEO SUMMARY: Business strategy does make a difference. However, it sometimes takes years to appreciate the wisdom of choosing one strategy over another. In the case of SmithKline Beecham’s lab division, the decision to become sole-source provider to the nation’s largest HMOs may event…
Expect ISO 9000 To Alter Clinical Lab Management
By Robert Michel | From the Volume V No. 9 – July 6, 1998 Issue
CEO SUMMARY: Perceptive laboratory executives and pathologists should welcome the impending arrival of ISO 9000 into the clinical laboratory industry. It promises to solve many problems of laboratory management. The diagnostics industry, responsible for manufacturing instruments and suppl…
Executive War College Goes International
By R. Lewis Dark | From the Volume V No. 8 – June 15, 1998 Issue
IT MAY SURPRISE MANY PEOPLE TO LEARN THAT THIS YEAR’S Executive War College in New Orleans attracted registrants from New Zealand and Germany. What may be even more surprising is the reason they traveled from overseas to come to this particular program. Our editor met with them and learne…
SmithKline May Merge With Glaxo Wellcome
By Robert Michel | From the Volume V No. 2 – February 9, 1998 Issue
CEO SUMMARY: Both companies confirm that merger talks are under way. The merger is another example of consolidation within the healthcare industry, and is expected to trigger mergers between other drug companies. Fate of SmithKline’s clinical laboratory division in the merger with Glaxo…
1997’s Top Ten Lab Stories Predict New Directions
By Robert Michel | From the Volume IV No. 18 – December 29, 1997 Issue
CEO SUMMARY: Events during 1997 reveal that the laboratory industry continues to undergo fundamental change. Yet even amidst the industry’s downsizing, selected laboratory organizations continue to flourish. Here is THE DARK REPORT’s annual look at top stories for the year. A careful …
California’s Rumor Mill Links LabCorp & Unilab
By Robert Michel | From the Volume IV No. 15 – October 27, 1997 Issue
CEO SUMMARY: Continued financial pressure on all laboratories operating in California leads some industry observers to believe that Laboratory Corporation of America and Unilab might be considering some kind of deal between the two companies. Senior executives at both laboratories say suc…
Management Philosophy Drives UroCor’s Success
By Robert Michel | From the Volume IV No. 9 – June 23, 1997 Issue
CEO SUMMARY: In the year 1997, UroCor shows a financial strength and growth potential unlike most commercial laboratories. UroCor’s current success is a direct result of how UroCor’s management did things differently during the years from 1991 to the present. Much of UroCor’s succes…
President Of SmithKline Lab Unit Respected As “Tough Competitor”
By Robert Michel | From the Volume IV No. 9 – June 23, 1997 Issue
WITH troubles at Corning/Quest and LabCorp attracting publicity during the previous 18 months, few people observed a discreet but important change at SmithKline Beecham Clinical Laboratories (SBCL). John B. Okkerse, Jr., Ph.D. has quietly assumed fu…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized